Investigating the inequalities in route to diagnosis amongst patients with diffuse large B-cell or follicular lymphoma in England J. Smith, Matthew Luque Fernández, Miguel Ángel Belot, Aurélien Quartagno, Matteo Bonaventure, Audrey Benitez Majano, Sara Rachet, Bernard Njeru Njagi, Edmund INTRODUCTION: Diagnostic delay is associated with lower chances of cancer survival. Underlying comorbidities are known to affect the timely diagnosis of cancer. Diffuse large B-cell (DLBCL) and follicular lymphomas (FL) are primarily diagnosed amongst older patients, who are more likely to have comorbidities. Characteristics of clinical commissioning groups (CCG) are also known to impact diagnostic delay. We assess the association between comorbidities and diagnostic delay amongst patients with DLBCL or FL in England during 2005–2013. METHODS: Multivariable generalised linear mixed-effect models were used to assess the main association. Empirical Bayes estimates of the random effects were used to explore between-cluster variation. The latent normal joint modelling multiple imputation approach was used to account for partially observed variables. RESULTS: We included 30,078 and 15,551 patients diagnosed with DLBCL or FL, respectively. Amongst patients from the same CCG, having multimorbidity was strongly associated with the emergency route to diagnosis (DLBCL: odds ratio 1.56, CI 1.40–1.73; FL: odds ratio 1.80, CI 1.45–2.23). Amongst DLBCL patients, the diagnostic delay was possibly correlated with CCGs that had higher population densities. CONCLUSIONS: Underlying comorbidity is associated with diagnostic delay amongst patients with DLBCL or FL. Results suggest a possible correlation between CCGs with higher population densities and diagnostic delay of aggressive lymphomas. 2024-10-03T06:34:57Z 2024-10-03T06:34:57Z 2021-08-13 journal article J Smith, M. et. al. Br J Cancer 125, 1299–1307 (2021). [https://doi.org/10.1038/s41416-021-01523-6] https://hdl.handle.net/10481/95445 10.1038/s41416-021-01523-6 eng http://creativecommons.org/licenses/by/4.0/ open access Atribución 4.0 Internacional Springer Nature